Diabetes Clinical Trials

Showing 6361-6380 of 7,874 trials

Racial/Ethnic Differences in Trust/Mistrust and Its Effect on Diabetes Outcomes

NCT00383110

1. Determine racial/ethnic differences in trust in physicians and mistrust of the health care system among veterans with Type 2 Diabetes. 2. Determine the predictive power of trust in physicians and mistrust of the health care system on personal health practices and health outcomes in a prospective cohort of veterans with Type 2 Diabetes

Diabetes

US Department of Veterans Affairs300 participantsStarted Nov 2004

Charleston, South Carolina, United States

COMPLETEDPhase 2

Study to Evaluate the Safety, Tolerability and Efficacy of Three Dose Levels of Mitoglitazone in Type 2 Diabetic Patients

NCT01103414

The purpose of this study is to evaluate the safety, tolerability and efficacy of three dose levels of Mitoglitazone™ (MSDC-0160) in patients with type 2 diabetes.

Type 2 Diabetes

Metabolic Solutions Development Company356 participantsStarted Sep 2010

Huntsville, Alabama, United States • Muscle Shoals, Alabama, United States • Chino, California, United States +21 more locations

Racial/Ethnic Differences in Trust/Mistrust and Its Effect on Diabetes Outcomes

Study to Evaluate the Safety, Tolerability and Efficacy of Three Dose Levels of Mitoglitazone in Type 2 Diabetic Patients

Related Searches

Bioequivalence of Two Insulatard® Formulations in Healthy Subjects

Effective Care Management of Depressed Diabetes Patients (The Positive Steps Study)

Nurse Telephone Management of Cholesterol in Diabetes

Diabetes Medication Choice

Adherence and Intensification of Medications (AIM) Implementation Study

Opportunistic Screening for Prediabetes and Early Diabetes in Primary Care

Bioequivalence Study

Estimation of Glomerular Filtration Rate (GFR) in Patients With Type 2 Diabetes Mellitus.

The OBSTACLE Hypoglycemia Study (MK-0000-158)

Metabolic Surgery Versus Medical Management for Resolution of Type II Diabetes

Safety of Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus Treated With Thiazolidinedione Alone or Thiazolidinedione in Combination With Metformin

Arginase Inhibition in Ischemia-reperfusion Injury

A Study of LY2189265 Compared to Sitagliptin in Participants With Type 2 Diabetes Mellitus on Metformin

Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of MBX-2982 Administered Daily for 4 Weeks as Monotherapy in Patients With Type 2 Diabetes

Effects of Vitamin D Supplementation in Subjects With New Onset of Type 1 Diabetes

Study Of Denagliptin In Subjects With Type 2 Diabetes Mellitus (T2DM)

MD-Logic Artificial Pancreas for Automatic Type 1 Diabetes Meals Management

Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Multiple Oral Bedtime Doses of ORMD-0801 in Adult Patients With Type 2 Diabetes Mellitus (T2DM)